Is Johnson & Johnson (JNJ) Stock Still a Value After 73% Rally?
After Johnson & Johnson (JNJ) stock surged 73.5% in one year, investors question whether the stock still holds value. This analysis explores what the current price might imply about the company.
Key Numbers
After Johnson & Johnson (JNJ) stock surged 73.5% over the past year and closed at $258.51, investors are questioning whether the stock still holds value. The stock also gained 11.8% over 7 days, 14.7% over 30 days, and 24.7% year-to-date. These strong returns naturally raise questions about what is already priced in.
Valuation Analysis
Valuation analysis suggests that the stock may be fairly valued at current levels, with a P/E ratio of around 16x, in line with the healthcare sector average. However, expected earnings growth in the coming years may not be sufficient to drive the stock significantly higher.
Recent Stock Performance
The stock has delivered strong returns across timeframes:
- 7 days: +11.8%
- 30 days: +14.7%
- Year-to-date: +24.7%
- 1 year: +73.5%
- 3 years: +72.7%
- 5 years: +76.1%
What This Means for Investors
Despite the strong performance, investors should consider factors like future growth and valuation before making any decisions. The stock may not be undervalued, but it is also not significantly overvalued. The focus remains on the company's fundamentals and its ability to deliver growth.
Frequently Asked Questions
Found this useful? Share it